Geri Stengel

Ida Tin is the founder of Clue and the Femtech Assembly, and directs the SPRIND Continuous Hormone Monitoring Challenge.

Natural Cycles, the first FDA-cleared birth control app, earned its sixth FDA clearance with a team led by three physicists who worked on the Higgs boson discovery at CERN. Their story reveals how particle-physics rigor, paired with clinicians who are also patients, closed one gap in women's health data.

Georgia Witchel's Mantis Biotech makes Parva, consumer software that reads how a person types and clicks to flag cognitive change relative to their own baseline, not a population average, largely built on men. The approach targets conditions that shift daily and disproportionately affect women: long COVID, ADHD, dementia, and perimenopause. Monthly appointments routinely miss these variations. Witchel, who built physics simulations to predict athletic injury before pivoting to cognitive care, argues that statistical AI fails at the individual level. Backed by $7.4 million led by Decibel, Parva reaches patients through ADHD, psychiatry, perimenopause, and neurology clinics. Pending FDA clearance, it flags risk rather than diagnosing, offering a continuous record where medicine was once measured by feel.

Vanessa Best, founder and CEO of Precision HealthCare Consultants, scaled her firm through certification and contracting rather than outside

What does it take to build a million-dollar Black-owned business? Vanessa Best shares the growth strategies that helped her scale without VC funding.

CMS proposed paying new labor-and-delivery codes 15% above its advisers' recommendation. The same 716 pages never say menopause. Comments close September 14.

CMS proposed paying new labor-and-delivery codes 15% above its advisers' recommendation. The same 716 pages never say menopause. Comments close September 14.

The Addition Wealth dashboard puts net worth tracking, financial health tools, a spending tracker, and an AI assistant in one place — with a human advisor a single click away.

Daye founder Valentina Milanova built a diagnostic tampon recognized by the NHS and TIME. Her story reveals the three gaps women's health founders must cross—and the fourth wall few survive.

Daye's at-home diagnostic tampon kit screens for HPV, STIs, and vaginal infections—bringing cervical cancer prevention out of the clinic and into a patient's own bathroom.